Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinhua Galaxy Biotechnology is a high-tech enterprise specializing in the research, development, production, and sales of probiotics and lactic acid bacteria. Founded in 2003 and based in Jinhua, China, the company operates as a wholly-owned subsidiary of Beijing Scitop Bio-tech (300858.SZ). It maintains a large-scale GMP-certified manufacturing facility for probiotic powders, solid beverages, and health supplements. The company's core technology focuses on proprietary probiotic strains such as Lactobacillus casei Zhang and Bifidobacterium lactis V9, which are utilized in food, healthcare, and agricultural applications. Jinhua Galaxy is recognized as a leading player in the Chinese probiotics industry, contributing to numerous scientific studies on gut health and immune modulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinhua Galaxy Biotechnology.